Neonatal Diagnostics Company InfanDx AG Launches US Operations
Retrieved on:
Tuesday, April 12, 2022
For the implementation of its US strategy, the Company incorporated a wholly-owned subsidiary, InfanDx USA, Inc. based in Boston, MA.
Key Points:
- For the implementation of its US strategy, the Company incorporated a wholly-owned subsidiary, InfanDx USA, Inc. based in Boston, MA.
- Dr. Achim Plum, CEO of the parent company InfanDx AG, will serve as President of InfanDx USA, Inc. To run all US operations, InfanDx hired Mr. Jordan deVos as VP of Operations, a seasoned industry expert with a track record in clinical trial management and business development.
- To this end, the Company has contracted GBC - Global BioClinical, a Seattle, WA, based CRO specializing in diagnostic clinical trials.
- InfanDx AG is a privately held company focusing on the development and commercialization of novel diagnostic solutions for acute and critical care conditions in newborns.